Stock Earnings

Question 1

CRISPR Therapeutics AGの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、CRISPR Therapeutics AGの総資産は$2,242で、純lossは$-366です。

Question 2

CRSPの主要な財務比率は何ですか？

Accepted Answer

CRISPR Therapeutics AGの流動比率は7.25、純利益率は-989.18、1株当たり売上高は$0.43です。

Question 3

CRISPR Therapeutics AGの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

CRISPR Therapeutics AG largest revenue segment is Genome-editing Technology, at a revenue of 37,314,000 in the most earnings release.For geography, Switzerland and United States is the primary market for CRISPR Therapeutics AG, at a revenue of 37,314,000.

Question 4

CRISPR Therapeutics AGは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、CRISPR Therapeutics AGの純lossは$-366です。

Question 5

CRISPR Therapeutics AGに負債はありますか？

Accepted Answer

yes、CRISPR Therapeutics AGの負債は309です。

Question 6

CRISPR Therapeutics AGの発行済株式数は何株ですか？

Accepted Answer

CRISPR Therapeutics AGの総発行済株式数は85.74株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	38	37	371	1	915	0
Revenue Growth (YoY)	-81%	-90%	37,000%	-100%	--	-100%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	233	183	206	212	102	88
Research & Development	283	320	387	461	438	266
Operating Expenses	516	503	593	674	541	355
Other Non Operating Income (Expenses)	89	103	71	22	6	6
Pretax Income	-484	-362	-150	-650	379	-348
Income Tax Expense	3	3	2	0	1	0
Net Income	-488	-366	-153	-650	377	-348
Net Income Growth	104%	139%	-76%	-272%	-208%	-627%
Shares Outstanding (Diluted)	91.3	84.35	79.22	77.7	80.4	65.9
Shares Change (YoY)	7%	6%	2%	-3%	22%	16%
EPS (Diluted)	-5.34	-4.34	-1.93	-8.36	4.7	-5.29
EPS Growth	91%	124%	-77%	-278%	-189%	-552%
Free Cash Flow	-328	-144	-272	-532	457	-256
Free Cash Flow Per Share	-3.59	-1.7	-3.43	-6.84	5.68	-3.88
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,257.89%	-1,259.45%	-59.83%	-67,300%	40.76%	0%
Profit Margin	-1,284.21%	-989.18%	-41.23%	-65,000%	41.2%	0%
Free Cash Flow Margin	-863.15%	-389.18%	-73.31%	-53,200%	49.94%	0%
EBITDA	-460	-447	-203	-649	391	-345
EBITDA Margin	-1,210.52%	-1,208.1%	-54.71%	-64,900%	42.73%	0%
D&A For EBITDA	18	19	19	24	18	9
EBIT	-478	-466	-222	-673	373	-354
EBIT Margin	-1,257.89%	-1,259.45%	-59.83%	-67,300%	40.76%	0%
Effective Tax Rate	-0.61%	-0.82%	-1.33%	0%	0.26%	0%

CRISPR Therapeutics AG (CRSP) Price

CRSP Stock Price Chart

CRSP Income

Follow-Up Questions